Literature DB >> 18631862

Fungal infections after lung transplantation.

Amparo Solé1, Miguel Salavert.   

Abstract

Lung transplantation (LT) is now considered to be the standard therapeutic intervention in some patients with end-stage pulmonary disease. Infectious complications after LT are relatively common due to the aggressive immunosuppression used in these receptors and local host factors derived from this type of transplant. The incidence of fungal infections after LT ranges up to 30%. However, the incidence of invasive mycoses has declined over the past decade. These mycoses are associated with high overall mortality rates despite increase of the antifungal armamentarium in the last years. Candida and Aspergillus spp produce most of these infections, but unusual moulds such as Scedosporium spp are increasingly recognized as opportunistic pathogens in LT. This review highlights the changing spectrum of invasive fungal infections, risk factors, antifungal prophylaxis, diagnosis, and treatment after LT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18631862     DOI: 10.1016/j.trre.2007.12.007

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN: 0955-470X            Impact factor:   3.943


  20 in total

1.  Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.

Authors:  Xuemei Wu; Raman Venkataramanan; Ryan M Rivosecchi; Chenxiao Tang; Rachel V Marini; Ryan K Shields; Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.

Authors:  Siow-Chin Heng; Gregory I Snell; Bronwyn Levvey; Dominic Keating; Glen P Westall; Trevor J Williams; Helen Whitford; Roger L Nation; Monica A Slavin; Orla Morrissey; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

3.  Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.

Authors:  Arthur W Baker; Eileen K Maziarz; Christopher J Arnold; Melissa D Johnson; Adrienne D Workman; John M Reynolds; John R Perfect; Barbara D Alexander
Journal:  Clin Infect Dis       Date:  2020-01-01       Impact factor: 9.079

4.  Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation.

Authors:  Fei Gao; Jingyu Chen; Dong Wei; Bo Wu; Min Zhou
Journal:  Front Med       Date:  2017-07-28       Impact factor: 4.592

Review 5.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

6.  Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.

Authors:  Florent Morio; Delphine Horeau-Langlard; Françoise Gay-Andrieu; Jean-Philippe Talarmin; Alain Haloun; Michelle Treilhaud; Philippe Despins; Frédérique Jossic; Laurence Nourry; Isabelle Danner-Boucher; Sabine Pattier; Jean-Philippe Bouchara; Patrice Le Pape; Michel Miegeville
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

7.  Management of Scedosporium apiospermum in a pre- and post-lung transplant patient with cystic fibrosis.

Authors:  Nancy E Rolfe; Tarik J Haddad; Todd S Wills
Journal:  Med Mycol Case Rep       Date:  2013-01-24

8.  Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.

Authors:  Xuemei Wu; Cornelius J Clancy; Ryan M Rivosecchi; Wenchen Zhao; Ryan K Shields; Rachel V Marini; Raman Venkataramanan; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

9.  Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?

Authors:  Rafael Zaragoza; Javier Pemán; Miguel Salavert; Angel Viudes; Amparo Solé; Isidro Jarque; Emilio Monte; Eva Romá; Emilia Cantón
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

10.  Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study.

Authors:  M Winkler; J Pratschke; U Schulz; S Zheng; M Zhang; W Li; M Lu; D Sgarabotto; G Sganga; P Kaskel; S Chandwani; L Ma; J Petrovic; M Shivaprakash
Journal:  Transpl Infect Dis       Date:  2010-01-11       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.